Catalog Products » HIB homolog 1 Antibody, mAb, Rabbit

HIB homolog 1 Antibody, mAb, Rabbit

Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates the ubiquitination of target proteins, leading most often to their proteasomal degradation. In complex with CUL3, involved in ubiquitination and proteasomal degradation of BRMS1, DAXX, PDX1/IPF1, GLI2 and GLI3.
$210.00
A04461-50

Ask us a question
Specificity This product is specific to HIB homolog 1
Host Species Rabbit
Immunogen A synthesized peptide derived from human HIB homolog 1
Species Reactivity Human
Conjugate Unconjugated
Back

Working concentrations for specific applications should be determined by the investigators. The appropriate concentrations may be affected by secondary antibody affinity, antigen concentration, the sensitivity of the method of detection, temperature, the length of the incubations, and other factors. The suitability of this antibody for applications other than those listed below has not been determined. The following concentration ranges are recommended starting points for this product.
Application Recommended Usage
Western Blot 1:1000-1:2000
Back

Form Liquid
Storage Buffer Supplied in 10mM phosphate buffered saline , pH 7.4, 150mM sodium chloride, 0.05% BSA, 0.02% sodium azide and 50% glycerol.
Storage Instructions Store at -20°C. This product is stable for 1 year upon receipt, when handled and stored as instructed.
Purification Affinity-chromatography
Isotype Rabbit IgG
Clonality Monoclonal
Back

HIB Homolog 1 Antibody, MAb, Rabbit

Western blot analysis of SPOP expression in HepG2 cell lysate. »

<
>

Target Background Component of a cullin-RING-based BCR (BTB-CUL3-RBX1) E3 ubiquitin-protein ligase complex that mediates the ubiquitination of target proteins, leading most often to their proteasomal degradation. In complex with CUL3, involved in ubiquitination and proteasomal degradation of BRMS1, DAXX, PDX1/IPF1, GLI2 and GLI3.
Synonyms BTBD32; SPOP; TEF2;
Back

For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.